SALKIND GENE purchased 200K shares of UPEXI, INC. on the open market
Open‑market purchase worth $546.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/18/2025ACC: 0001477932-25-008466
Director10% Owner
+200K
Net shares
Net buyer
$546.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
200K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100K
Price / share
$2.65
Trade value
$265K
% of position
21.3%
—
469.47K→569.47K
Common Stock
Indirect
Shares
+100K
Price / share
$2.81
Trade value
$281K
% of position
145.5%
—
68.75K→168.75K
Total
Net shares
+200K
Net value
$546K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +100K | $2.65 | $265K | 21.3% | 469.47K | 569.47K |
| Common Stock Indirect | — | P · Purchase | +100K | $2.81 | $281K | 145.5% | 68.75K | 168.75K |
| Total | +200K | $546K | ||||||
Derivative Transactions0
No derivative transactions reported